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S U M M A R Y
Objectives: The objective of this study was to investigate HIV knowledge and its relation to HIV stigma
among health science students and pharmacists in Guyana, South America. This study also evaluated
how the Public Health Strengthening in Guyana Project’s (PHSGP) HIV/AIDS/STI educational initiatives
inﬂuenced HIV knowledge levels among health science students at the University of Guyana.
Methods: A total of 119 individuals, consisting of pharmacists (n = 42) and health science students
(n = 77) participated in this cross-sectional study. All participants completed validated measures of HIV
knowledge and HIV stigma.
Results: Overall, health science students scored high on knowledge about HIV risk factors and modes of
HIV infection, but were less knowledgeable aboutmore complex HIV treatment issues such as adherence
and drug resistance. Students who had received educational HIV training had signiﬁcantly higher levels
of HIV knowledge than those who had not received training. Pharmacists had excellent knowledge
regarding HIV risk factors and modes of infection, but had some important gaps in knowledge regarding
the importance of HIV medication adherence and drug resistance. Overall, low levels of HIV stigma were
endorsed, and those with higher HIV knowledge reported lower HIV stigma.
Conclusions: Although the HIV curriculum has enhanced HIV knowledge, gaps in HIV knowledge remain,
such as complex HIV treatment issues. The results of this study are discussed within the context of the
challenges of HIV capacity building in resource-poor countries.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Despite widespread media attention on HIV/AIDS, substantial
misconceptions and gaps in HIV knowledge still exist in the general
public and among health care workers. To date, most of the
research on HIV knowledge levels among health care workers (e.g.
pharmacists, dentists, physicians) has been conducted in Western
world contexts such as the USA1 and Europe.2,3 Only recently have
researchers begun to explore HIV knowledge among health care
workers in more diverse countries such as Nigeria,4 Vietnam,5
Pakistan,6 Iran,7 and India.8 Examining the types of HIV knowledge
gaps that exist in diverse countries and exploring culturally
sensitive ways of addressing these gaps is critical given that the
HIV epidemic is widespread in many developing countries.4 Most* Corresponding author. Tel.: +1 613 737 8039; fax: +1 613 737 8895.
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health care systems, which only exacerbates the harmful impact of
the HIV/AIDS epidemic.
Existing research ﬁndings must be within the context of the
post-highly active antiretroviral therapy (HAART) era, character-
ized by complex treatment issues such as optimal HIV medication
adherence and drug resistance. Previous studies assessing HIV
knowledge ignored these more complex treatment issues.
Furthermore, these studies did not use psychometrically validated
HIV knowledge scales. Recently, a validated HIV treatment
knowledge scale was developed that allows for a reliable
assessment of current HIV treatment knowledge among indivi-
duals.9
Guyana, which lies on the South Americanmainland, is a part of
the Caribbean Community (CARICOM), with a small population of
approximately 751 000 (United Nations, 2007). Guyana is one of
the poorest countries in the world, with a gross domestic product
(GDP) per capita of US$1219 in 2006.10 Guyana also has the secondses. Published by Elsevier Ltd. All rights reserved.
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region and is one of the few Caribbean countries whose HIV/AIDS
epidemic has entered the general population.11 The estimated
prevalence of HIV infection in Guyana is 2.4% (range 1.0–4.9%), and
an estimated 1200 Guyanese died of HIV/AIDS in 2005.11 AIDS and
AIDS-related complications are currently the leading cause of
death in the 25–44 years age group in Guyana.12
Economically and socially, Guyana is struggling to recover from
decades of under-development. HIV/AIDS is therefore a consider-
able drain on the human and health resources of Guyana, and it
threatens the country’s economic development. As in most
developing countries, HIV/AIDS affects the most productive age
group (20–49 years), hence HIV/AIDS contributes to the poverty
and vulnerability of people living with HIV/AIDS (PHA) and their
families in Guyana.
In response to the HIV/AIDS crisis in Guyana, the governments of
Canada and Guyana developed the Public Health Strengthening in
Guyana Project (PHSGP) in 2004. The PHSGP was funded by the
Canadian Government through the Canadian International Devel-
opment Agency (CIDA), and was designed and implemented by the
Canadian Society for International Health (CSIH). One goal of the
PHSGP was to build and strengthen the national capacity to
implement, provide, and sustain HIV/AIDS prevention andmanage-
ment. As such, the PHSGP developed training and mentoring
programs on the clinical management of HIV/AIDS/sexually
transmitted infections (STI) as part of the training for health care
students. The project developed and implemented a core course on
HIV/AIDS/STI for the Faculty of Health Sciences at the University of
Guyana. The University of Guyana is the only publicly funded
university in the country of Guyana. The University of Guyana has a
student body of approximately 5000 students/year with an average
of 297 students registered in the Faculty of Health Sciences in the
programs of medical technology (n = 85), pharmacy (n = 82), school
of medicine (n = 94), and public health (n = 56) (www.uog.edu.gy/
administration/vice-chancellor/ormp/fte).
In addition, within the context of its long-term goals, the PHSGP
has offered continuing education sessions and mentoring in HIV/
AIDS for health professionals throughout Guyana.
A secondary goal of the PHSGP was to reduce HIV-related
stigma among health care workers and the general population
through education. Negative social stigma about HIV/AIDS is a
signiﬁcant obstacle to the successful uptake of programs for HIV
prevention, testing, and treatment.13 Stigma can take the form of
blatant and extreme forms of discrimination, as well as more
subtle forms of stigma expressed through non-verbal communi-
cation, body language, and tone of voice. Only recently, have
researchers begun to examine systematically the impact of HIV
stigma in developing world contexts. For example, a 2007 study
conducted in Pakistan showed that in a sample of 291 medical
students, 34% said they would avoid someone if they had AIDS and
23% believed that PHAs should not be allowed to attend
government schools.6 In Vietnam, 40% of physicians reported
feeling somewhat uncomfortable touching HIV/AIDS patients
during examination or treatment and 73% worried that they
might contract HIV from their HIV patients.5 It is encouraging that
83% of Belize physicians and nurses (n = 230) in 2008 reported
feeling comfortable providing health services to PHAs. However,
45% of these same health care workers felt more sympathy for
those who had acquired AIDS from blood transfusions than from
intravenous drug use, and 21% felt ‘‘little sympathy for people who
get AIDS from sexual promiscuity’’.14 To date, no research has
examined HIV stigma in Guyana or the relationship between HIV-
related education and reductions in HIV-related stigma.
The main goal of this study was to examine levels of HIV
awareness and gaps in HIV knowledge among health care students
and pharmacists, and to examine how gaps in knowledge mayrelate to HIV stigma in Guyana. We expected that pharmacists
would have higher HIV knowledge scores than students. Medical
and pharmacy students were expected to have higher HIV
knowledge scores than medical technology students.
A second goal was to assess the relationship between HIV
knowledge and stigma among Guyanese pharmacists and health
science students. We hypothesized that lower levels of HIV
knowledge would be related to higher levels of HIV stigma.
A third goal of this study was to evaluate the utility of the
PHSGP education initiative. To do so, we compared HIV knowledge
levels among University of Guyana students who had received HIV
training as part of the PHSGP to students who had not yet received
this targeted HIV educational training. Students who received the
PHSGP training in HIV were expected to have higher HIV
knowledge scores than students without the training.
This study employed psychometrically validated measures to
assess both general HIV knowledge and complex HIV treatment
knowledge issues. To date, no research has examined HIV
knowledge in Guyana, nor has research evaluated the impact of
HIV training programs on students’ HIV knowledge. This study
aimed to identify the gaps in HIV knowledge that need to be
addressed in tailoring new HIV educational training programs in
Guyana and other developing countries.
2. Methods
2.1. Participants and procedures
Participants were university health science students and
pharmacists in Georgetown, Guyana recruited from January 2007
through February 2007. First, second, and third year undergraduate
students from the health sciences degree program (e.g., medicine,
pharmacy, andmedical technology students) were recruited during
ahealthseminar seriesat theUniversityofGuyana,Georgetown,and
all students who attended the health seminar series participated in
thestudy.Pharmacistswererecruitedduringacontinuingeducation
workshop. Of the 45 pharmacists attending the continuing
education workshop, 93% (n = 42) agreed to participate in this
study. The three pharmacists who did not participate were late
arrivals at the workshop. Although the 42 pharmacists who
participated in this study were a convenience sample, these
pharmacists provide a fairly good representative sample of the
entire population of practicing pharmacists (n = 133) in the entire
country of Guyana at the time of data collection (communication
between the Registrar, The Pharmacy Council of Guyana and Dr
Wallis Best Plummer). Pharmacists were chosen in this study
because in Guyana pharmacists are frontline health care workers
who typically have contact with HIV patients. The main language
spoken inGuyana is English and all study participantswereﬂuent in
English.
All participants completed a socio-demographic questionnaire,
HIV knowledge questionnaires, and an HIV stigma questionnaire.
At the beginning of the seminar or workshop, participants were
informed about the study goals and issues of conﬁdentiality. All
participants provided written informed consent prior to partici-
pating. The questionnaire package required about 15 minutes to
complete. All aspects of the study were approved by the
Institutional Review Board at the Ministry of Health, Guyana.
2.2. Measures
Socio-demographic characteristics were collected through a
self-report measure which assessed participant gender, ethnicity,
education, employment, and HIV training experience.
The HIV Brief Knowledge Questionnaire15,16 was used to assess
knowledge of HIV disease (e.g., transmission, progression, and
Table 1
HIV risk factor, transmission, and prevention knowledge (% correct) among students and pharmacists
Scale itema Students % Pharmacists %
(n=42)
No PHSGP
HIV training
(n=23)
PHSGP
HIV training
(n=54)
1. Coughing and sneezing DO NOT spread HIV. (T) 100 89 88
2. A person can get HIV by sharing a glass of water with someone who has HIV. (F) 96 89 98
3. Pulling out the penis before a man climaxes/cums keeps a woman from getting HIV during sex. (F) 83 93 100
4. A woman can get HIV if she has anal sex with a man. (T) 96 93 91
5. Showering, or washing one’s genitals/private parts, after sex keeps a person from getting HIV. (F) 100 98 100
6. All pregnant women infected with HIV will have babies born with AIDS. (F) 74 85 86
7. People who have been infected with HIV quickly show serious signs of being infected. (F) 96 94 95
8. There is a vaccine that can stop adults from getting HIV. (F) 87 89 95
9. People are likely to get HIV by deep kissing, putting their tongue in their partner’s mouth,
if their partner has HIV. (F)
65 57 50
10. A woman cannot get HIV if she has sex during her period. (F) 91 96 100
11. There is a female condom that can help decrease a woman’s chance of getting HIV. (T) 70 83 91
12. A natural skin condom works better against HIV than does a latex condom. (F) 48 63 74
13. A person will NOT get HIV if she or he is taking antibiotics. (F) 96 91 100
14. Having sex with more than one partner can increase a person’s chance of getting infected with HIV. (T) 100 96 98
15. Taking a test for HIV one week after having sex will tell a person if she or he has HIV. (F) 74 85 93
16. A person can get HIV by sitting in a hot tub or a swimming pool with a person who has HIV. (F) 91 98 98
17. A person can get HIV from oral sex. (T) 74 70 62
18. Using Vaseline/baby oil with condoms lowers the chance of getting HIV. (F) 74 80 95
Note. Percentages are rounded to the nearest whole number. Correct responses appear in brackets, F, false; T, true. PHSGP, Public Health Strengthening in Guyana Project.
a Items from the Brief HIV Knowledge Questionnaire (Carey and Schroder, 2002).16
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Table 1 for scale items). A total score is calculated by summing the
number of correct responses and dividing by the total number of
scale items. This yields a percentage of correct responses, with
higher scores indicating greater general HIV knowledge. The
measure demonstrated good internal consistency across samples,
with coefﬁcient alphas ranging from 0.75 to 0.89.9,16 This scale is
reliable and well-validated.15,16
The validated 21-item self-report HIV Treatment Knowledge
Scale9 was used to assess knowledge about complex HIV treatmentTable 2
HIV treatment knowledge (% correct) among students and pharmacists
Scale itema
1. Once the HIV viral load results are ‘undetectable’, HIV medications should be sto
2. If HIV medications are not taken at the right time of day, HIV drug resistance can
3. HIV is cured when the HIV viral load blood test result is ‘undetectable’. (F)
4. Condoms during sex are not needed when the HIV viral load blood test
results are at ‘undetectable’ levels. (F)
5. It is better to take a half dose of HIV medications than stopping the HIV combina
medications completely. (F)
6. One can get infected with a drug-resistant type of HIV. (T)
7. HIV medications can cause unpleasant side effects (e.g., nausea, diarrhea, vomitin
8. If sexual partners are both HIV-positive condoms are no longer needed. (F)
9. Treatments are available to reduce HIV medication side effects. (T)
10. Recreational drugs (e.g., ecstasy) can affect the effectiveness of HIV medications.
11. Providing HIV medications to a pregnant woman reduces the baby’s risk of being
infected with HIV. (T)
12. There currently exists an HIV vaccine that prevents HIV infection. (F)
13. HIV medications can be taken at a different time of day on weekends or holidays
14. Over-the-counter herbal pills (e.g., St. John’s Wort) could make HIV
medications less effective. (T)
15. It is best to stop HIV medications as soon as you feel better. (F)
16. Missing a few doses of HIV pills can increase the amount of HIV virus in the bod
17. After a few months, it becomes less important to take HIV medications at
the right time of day. (F)
18. HIV medications help the body’s immune system get stronger (CD4 increase). (T)
19. When HIV medications work well, the HIV viral load increases. (F)
20. Taking antibiotic medication protects a person from getting infected with HIV. (F
21. Physical exercise (e.g., yoga, tai chi) can help reduce stress levels in HIV patients
Note. Percentages are rounded to the nearest whole number. Correct responses appear
a Items from the HIV Treatment Knowledge Scale (Balfour et al., 2007).9issues such as adherence, side-effects, and drug resistance (see
Table 2 for scale items). Participants indicated whether each
knowledge item was ‘true’ or ‘false’, or, if they ‘don’t know’ the
answer.A total score is calculatedbysumming thenumberof correct
responsesanddividingbythe totalnumberof scale items.Thisyields
a percentage of correct responses, with higher scores indicating
greater HIV treatment knowledge. This scale demonstrated good
internal consistency (alpha = 0.90), test–retest reliability (r = 0.81),
and validity in a number of samples, including HIV patients, health
care workers, and university students in Canada.9Students % Pharmacists %
(n=42)
No PHSGP HIV
training (n=23)
PHSGP HIV
training (n=54)
pped. (F) 65 70 88
occur. (T) 35 54 74
61 83 100
83 96 100
tion 26 44 76
48 57 71
g). (T) 74 83 95
78 94 95
44 61 71
(T) 30 52 52
91 83 93
57 65 76
. (F) 52 52 86
26 15 50
100 96 100
y. (T) 52 70 81
78 91 98
70 80 81
78 69 86
) 83 94 98
. (T) 91 93 95
in brackets, F, false; T, true. PHSGP, Public Health Strengthening in Guyana Project.
Table 3
Demographics for health science students and pharmacists in Guyana
Variable Health science
students (n=77)
Pharmacists
(n=42)
Age (mean SD) 20.802.34a 34.189.09
Sex
Male 22 (28.9%)a 18 (42.9%)
Female 54 (71.1%) 24 (57.1%)
Ethnic background
East Indian 39 (50.6%) 22 (52.4%)
African 16 (20.8%) 10 (23.8%)
Mixed (African/East Indian) 21 (27.3%) 8 (19.0%)
Amerindian 1 (1.3%) 1 (2.4%)
SD, standard deviation.
a Data missing for one participant.
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StigmaScale.17 TheAIDS-relatedStigmaScale is abrief, 12-itemself-
report measure that assesses attitudes in the general population
regarding HIV stigma beliefs (e.g., repulsion, avoidance, and
persecution) about individuals livingwithHIV/AIDS. The instrument
is rated on a 4-point Likert-type scale (0 = strongly disagree to
3 = strongly agree), with higher scores indicating greater perceived
HIV stigma. This scale was used in South African communities, and
demonstrated good reliability (alpha = 0.72) and validity.17–19
2.3. Data analysis
All analyses were conducted using SPSS v.15 (SPSS Inc., Chicago,
IL, USA). Datawere initially screened in accordancewith procedures
outlined by Tabachnick and Fidell (2001), and statistical assump-
tions were evaluated.20 Descriptive statistics were used to evaluate
the percentage of correct responses on theHIV knowledge scales for
each sample and to evaluate the responses to the individual scale
items. One-way analysis of variance (ANOVA) was used to compare
the percentage of correct responses to the HIV knowledge scales
among the different student groups (e.g., medical vs. pharmacy vs.
medical technology students). Independent samples t-tests were
used to compare: HIV knowledge scores of students versus
pharmacists, HIV knowledge scores of students who received the
PHSGP training in HIV versus those who did not receive the PHSGP
training in HIV, and the HIV stigma scores of students who received
the PHSGP training in HIV versus those who did not receive the
PHSGP training in HIV. Levene’s test for equality of variances was
used to assess for the assumption of homogeneity of variances.
When this assumption was violated, a t-test for unequal variances
was used, which accounts for heterogeneous variances. Effect sizes
were calculated using Cohen’s d, indicating small (>0.20), medium
(>0.50), and large (>0.80) effects, and partial eta squared (hp
2),
indicating small (>0.01), medium (>0.06), and large (>0.14)
effects.21 Pearson product moment correlations were conducted
to evaluate the relationship betweenHIV knowledge scores andHIV
stigma.
3. Results
3.1. Participant characteristics
Ninety-three percent of pharmacists and 100% of students
approached to participate in the study agreed to enroll in the study.
The ﬁnal sample (n = 119) consisted of health science students
(n = 77) and pharmacists (n = 42). Socio-demographic character-
istics for both samples are presented in Table 3. Over a third of the
students (38%) were medical students, 33% were pharmacy
students, and 30% were medical technology students, which
parallels the proportion of students enrolled in each of these
respective disciplines in the Health Sciences Program at The
University of Guyana. Seven percent of students were in their ﬁrst
year at university, over half of the students (64%) were in theirTable 4
Mean percentage of correct responses to the HIV knowledge scales
Sample n Brief HIV Knowledge Scale, % SD
Students with no PHSGP HIV training 23 84.0611.88
Students with PHSGP HIV training 54 86.119.70
Total students 77 85.5010.36a
Total pharmacists 42 89.557.28a
Note. SD, standard deviation; PHSGP, Public Health Strengthening in Guyana Project. M
a Signiﬁcant difference at p  0.05.
b Signiﬁcant difference at p  0.001.
c Signiﬁcant difference at p  0.05.second year, and 30% were in their third year. Thus, most of the
students sampled in this study were in the second and third years
of their university degree programs in their respective health
sciences disciplines, because the health seminar series was
directed at second and third year university students.
Seventy percent (n = 54) of the students had received the PHSGP
training in HIV while 30% (n = 23) of the students had not.
3.2. HIV and risk factor knowledge
The distribution of the Brief HIV Knowledge Scale was
moderately negatively skewed, and a square root transformation
corrected this violation of normality. Independent samples t-tests
and one-way ANOVAs were conducted using the transformed Brief
HIV Knowledge variable.
ThemeanscoresongeneralHIVknowledge (BriefHIVKnowledge
Scale) are presented in Table 4. As predicted, pharmacists (n = 42)
reported signiﬁcantly higher HIV knowledge (89.55%  7.28) than
health science students (n = 77; 85.50% 10.36), t(117) = 2.11,
p < 0.05, and the effect size was d = 0.45.
When the percentages of correct responses to the Brief HIV
Knowledge Scale were compared across student groups (e.g.,
medical vs. pharmacy vs. medical technology students), no
signiﬁcant overall effect was observed, F(2,74) = 2.46, p = 0.09. An
independent samples t-test revealed that, contrary to expectation,
there was no statistically signiﬁcant difference between students
with PHSGP training in HIV and students without PHSGP training in
HIV in terms of their general HIV knowledge, t(75) = 0.568, p = 0.57.
The effect size, d = 0.13, was small.
The responses of students (with and without PHSGP training in
HIV) and pharmacists to individual general HIV knowledge scale
items are presented in Table 1.
3.3. HIV treatment knowledge
The mean scores on the HIV Treatment Knowledge Scale are
presented in Table 4. As predicted, pharmacists (n = 42) reported
signiﬁcantly higher HIV treatment knowledge (84.13%  11.31)HIV Treatment Knowledge Scale, % SD HIV Stigma Scale, mean SD
62.9420.60c 1.641.28
71.6016.49c 1.741.60
69.0218.13b 1.671.37
84.1311.31b 1.311.28
eans with same subscript are signiﬁcantly different.
Table 5
HIV-related stigma items endorsed by health sciences students and pharmacists
Scale itema Students % Pharmacists %
(n=42)
No PHSGP HIV
training (n=23)
PHSGP HIV
training (n=54)
1. People who have HIV/AIDS are cursed 0 0 0
2. It is safe for people who have HIV/AIDS to work with children 74 69 83
3. People who have HIV/AIDS should be ashamed 4 6 5
4. People who have HIV/AIDS have nothing to feel guilty about 65 65 76
5. People who have HIV/AIDS should be isolated 22 9 5
6. I do not want to be friends with someone who has HIV/AIDS 4 6 7
7. People who have HIV/AIDS should not be allowed to work 4 6 7
8. A person with HIV/AIDS must have done something wrong and deserves to be punished 0 2 2
9. People who have HIV/AIDS cannot be trusted 4 4 7
10. People with HIV/AIDS must expect some restrictions on their freedom 52 43 50
11. Most people become HIV-positive by being weak or foolish 22 26 7
12. People who have HIV/AIDS are dirty 0 0 0
Note. Percentages are rounded to the nearest whole number. PHSGP, Public Health Strengthening in Guyana Project.
a Items adapted from the AIDS-related Stigma Scale (Kalichman et al., 2005).17
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p < 0.001. The effect size was large, d = 1.0.
The percentages of correct responses to the HIV Treatment
Knowledge Scale were compared across student groups (e.g.,
medical students vs. pharmacy students vs. medical technology
student). A one-way ANOVA indicated that the overall effect
approached statistical signiﬁcance, F(2,74) = 2.98, p = 0.057, and the
effect size was medium, hp
2 = 0.07. Post-hoc Tukey tests revealed
that, as hypothesized, pharmacy students (74.48%  15.67) scored
signiﬁcantly higher on the HIV Treatment Knowledge Scale than
medical technology students (62.11%  21.51), and the effect size was
medium (d = 0.66). There was no statistically signiﬁcant difference
between the HIV Treatment Knowledge Scale scores of the medical
students (69.79%  15.86) and pharmacy students, p = 0.60, nor
between the medical students and medical technology students,
p = 0.27, and the effect sizes were small, d = 0.3 and d = 0.4,
respectively.
An independent samples t-test revealed, as expected, that
students with PHSGP training in HIV (71.60%  16.49) had
signiﬁcantly higher HIV treatment knowledge scores than students
without PHSGP training in HIV (62.94%  20.60), t(75) = 1.96,
p = 0.05, and the effect size was d = 0.46.
Table 2 presents the responses to theHIV Treatment Knowledge
Scale items for pharmacists, as well as students with and without
PHSGP training in HIV.
3.4. HIV stigma levels
Overall, low levels of HIV stigmawere endorsed by pharmacists
and health science students (see Table 5). As expected, HIV stigma
was signiﬁcantly negatively correlated with general HIV knowl-
edge among health science students (n = 77, r = 0.23, p < 0.05),
and HIV stigma was signiﬁcantly negatively correlated with HIV
treatment knowledge among pharmacists (n = 42, r =  0.49,
p < 0.001). Contrary to expectation, there was no statistically
signiﬁcant difference between students with PHSGP HIV training
and students without PHSGP HIV training in terms of their HIV
stigma, t(75) = 0.30, p = 0.77, and the effect size was small,
d = 0.07.
4. Discussion
Overall, the level of general HIV knowledge regarding HIV risk
factors, transmission, and prevention was high among both
university health science students (85.50% correct) and pharma-
cists (89.55% correct). The main gaps in knowledge pertained to
mother-to-child transmission, effective use of condoms, and thetimeframe of HIV seroconversion. For example, more than 20% of
students were unaware that using Vaseline with condoms
increases the chance of HIV transmission. Further, many students
and pharmacists were not aware that HIV could be transmitted
through oral sex and ‘natural skin’ condoms. These results suggest
that continuing HIV education initiatives need to be altered to
speciﬁcally target these speciﬁc HIV transmission issues regarding
sexual acts/behaviorswhichmay not be easily discussed in Guyana
due to cultural and religious beliefs.
Therewerenosigniﬁcantdifferences ingeneral knowledgeabout
HIV risk factors between studentswithHIV training (86.11% correct)
versus those without HIV training (84.06% correct) suggesting that
health science students’ baseline knowledge of general HIV
transmission risk factors is fairly good. There were, however,
signiﬁcant differences in HIV treatment knowledge between
students with HIV training (71.60% correct) as compared to those
without training (62.94% correct). This suggests that the PHSGPHIV
training curriculum did help increase HIV treatment knowledge
amonghealth science students.However, evenwithPHSGP training,
important gaps in HIV treatment knowledge still need to be
addressed, speciﬁcally in terms of complex HIV treatment and
transmission issues. That is,many health science students lacked an
appreciation of the need for optimal HIVmedication adherence and
how poor adherence could contribute to HIV drug resistance.
Furthermore, approximately 40% of the total sample of health
science students incorrectlybelieved that there is apreventativeHIV
vaccine, andmanydidnot understand the importanceof adhering to
theHIVmedication-dosing schedule (e.g.,many incorrectlybelieved
that itwas better to take half a dose ofHAART than stop completely).
It should be noted, that although we would expect medical
technology students to have lower HIV treatment knowledge scores
(62.11% correct), as compared to medical students (69.79% correct)
andpharmacy students (74.48% correct), overall the scores across all
three groups of students are sub-optimal.
In terms of comparing HIV treatment knowledge levels
between students and pharmacists, health science students had
lower levels of HIV treatment knowledge (69.02% correct) as
compared to pharmacists (84.13% correct), indicating that students
were less informed aboutmore complex HIV treatment issues such
as adherence, side-effects, and drug resistance. Although, the
average HIV treatment knowledge score for pharmacists (84.13%)
might seem acceptable, there were several key gaps in knowledge
of concern. For example, only 71% of pharmacists knew that ‘‘one
can become infected with a drug-resistant type of HIV’’. The public
health care implications of this gap in HIV treatment knowledge
among pharmacists, who are frontline HIV workers, could be quite
harmful.
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levels of knowledge on the potential impact of recreational drugs
(e.g., ecstasy) and over-the-counter herbal pills (e.g., St. John’s
Wort) on the effectiveness of HIV medications. Although previous
research using the HIV Treatment Knowledge Scale has identiﬁed
that Canadian health care workers and students also have low
scores on these scale items,9 the Guyanese sample scored lower,
possibly due to differences in social and cultural contexts. That is,
ecstasy and St. John’s Wort may not be common in Guyana, and
perhaps item examples such as ‘ganja’ or ‘bushmedicine’ may have
been more relevant. Thus, items on the HIV Treatment Knowledge
Scale item examples may need to be tailored to different contexts
and countries so that future research is more culturally relevant.
This Guyanese samples’ lack of awareness about the need for
optimal HIV medication adherence and the risk of HIV drug
resistance is consistent with ﬁndings among health care workers
and social science students in Canada,9 pharmacists in Scotland,22
and pharmacists in South Africa.23 The results of this and previous
studies suggest that these HIV treatment issues warrant particular
attention in targeted training programs for both health care
students and workers in both developed and developing countries.
One of the potential negative effects of low HIV knowledge is
health care worker stigma with regard to their perception of PHAs.
Stigma is deﬁned as a complex, multidimensional social and
psychological phenomenon that discredits, disqualiﬁes, and denies
an individual societal acceptance as a whole person.24–26 Stigma-
tized people lose social status, as they are not viewed as full
members of society; they are rejected and marginalized. HIV is
particularly stigmatizing because it is infectious, with visible
physical signs of illness (e.g., wasting, Kaposi’s sarcoma, lipody-
strophy), and HIV is associated with sexual behavior, perceived
personal responsibility (e.g., victim blaming), and negatively
regarded social groups (e.g., injection drug users).26,27 Among
PHAs, HIV stigma may increase feelings of social isolation and
shame, which contributes to fears of accessing HIV health care
services and poorer HIV treatment success rates.13,27–29
Consistent with international research,8 results of this study
showed that pharmacists in Guyana who are less knowledgeable
about HIV endorse higher levels of HIV stigma. Stigma may
negatively impact the uptake of HIV knowledge, thereby potentially
increasing the spreadofHIV. Forexample, ina sampleof162Kuwaiti
familyphysicians, 90%disapprovedof condomuse toprotect against
HIV, 70% believed homosexuality is a psychiatric illness, and 84%
would quarantine PHAs to stop the spread of HIV infection.30
Researchers consistently demonstrate that health careworkerswho
receiveHIV trainingandbecomemoreknowledgeableaboutHIVare
less likely to hold exaggerated fears of contracting HIV and are less
likely to refuse to work with PHAs.8,30,31
In the current study, pharmacists and health science students in
Guyana did not report extreme levels of HIV stigma. That is, the
samples did not report that PHAs are ‘cursed’, ‘dirty’, or ‘deserve to
be punished’. However, more subtle forms of HIV stigma were
present. For example, almost 25% of pharmacists sampled in
Guyana believed people with HIV/AIDS should feel guilty, and 50%
believed that PHAs must expect some restrictions on their
freedom. The results of the present study also suggest that more
subtle forms of HIV stigma were related to HIV knowledge, and
that these more subtle expressions of stigma need to be addressed
in HIV educational curriculums.
While the backbone of comprehensive HIV educational
programs must always focus on up to date medical knowledge
about HIV risk factors, modes of transmission, clinical symptoms,
and HIV treatment options, it is also important to highlight the
emotional impact of subtle forms of HIV stigma. Unfortunately,
most HIV educational training programs neglect the emotional
aspects of working with people who are living with HIV (PHAs).Training initiatives are needed to raise health care workers’
awareness of how PHAs experience social rejection, emotional
isolation, depression, discrimination, fears of abandonment, and
stigma. As well, sensitivity training to help health care workers
reﬂect on their own conscious and unconscious feelings, attitudes,
and comfort level in discussing topics such as anal sex, oral sex, sex
for money, condom use, street drug use, and pregnancy attempts
among HIV-positive couples is important. Discomfort in discussing
any of these topics could inﬂuence the full scope of how health care
providers approach, assess, and counsel their patients. In Barbados,
76% of physicians felt that they lacked the skills to counsel HIV-
positive patients.32 Thus, it is imperative that HIV educational
programs provide training workshops on strategies to facilitate
more open communication and dialogues with PHAs regarding
sensitive topics, such as sex and drug use.
There are several limitations to this study. First, the PHSGP
curriculum on HIV knowledge in health science students was
evaluated using a cross-sectional design, not a controlled pre–post
design. However, no prior studies have evaluated the impact of
such initiatives on HIV knowledge levels in Guyana. The current
study provides a much-needed indication of the effectiveness of
the PHSGP educational initiative. Future longitudinal studies
should assess health science students’ HIV knowledge levels
before and after the PHSGP course at the University of Guyana. We
recommend that program outcome evaluation using psychomet-
rically validated instruments like those in this study be considered
from the outset when planning and developing future HIV
educational initiatives.
A second limitation is that the sample size is small, thus
potentially reducing the reliability of the results. As well, the
current study used a convenience sample of pharmacists and it is
unclear how results obtained from these pharmacists would
generalize to other health care workers in Guyana (e.g., nurses,
physicians). Nonetheless, given the low base rates of total
pharmacists practicing in Guyana (n = 133), the participants
sampled in this study were reasonably representative of practicing
pharmacists in Guyana. Future research could assess HIV
knowledge and stigma in a broader sample of health care workers
in both urban and more remote rural communities in Guyana.
Another limitation is that the HIV knowledge scales used in the
study were developed and validated in North America.9,15,16 In
addition, the AIDS-related stigma scale used in the study was
developed and validated in South Africa.17–19 As noted earlier,
some of the scale items may not be as culturally relevant in
Guyana. Thus, future research needs to validate and adapt the HIV
knowledge items and HIV stigma items to ensure greater cross-
cultural sensitivity and relevance.
In conclusion, the PHSGP curriculum signiﬁcantly enhanced
HIV knowledge in health sciences students in Guyana, yet some
gaps in HIV knowledge still need to be addressed. Educational
initiatives for pharmacists and health science students aimed at
increasing HIV knowledge and reducing HIV stigma are important
steps towards reducing fears of treating HIV, enhancing HIV
prevention efforts, improving medical access to HIV care, and
ultimately improving HIV treatment outcomes. Addressing HIV
knowledge and psychosocial aspects of HIV stigma are corner-
stones to optimizing the ﬁght against HIV worldwide.
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